[Plans-Rubió P] Agència de Salut Pública de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
Departament de Salut
2024-05-13T10:33:19Z
2024-05-13T10:33:19Z
2019-07-18
HDL colesterol; LDL colesterol; Lípids sanguinis; Estudi multinacional
HDL colesterol; LDL colesterol; Lípidos en sangre; Estudio multinacional
HDL colesterol; LDL colesterol; Blood lípids; Multi-country study
Background: Although high-density lipoprotein (HDL) and non-HDL cholesterol have opposite associations with coronary heart disease, multi-country reports of lipid trends only use total cholesterol (TC). Our aim was to compare trends in total, HDL and non- HDL cholesterol and the total-to-HDL cholesterol ratio in Asian and Western countries. Methods: We pooled 458 population-based studies with 82.1 million participants in 23 Asian and Western countries. We estimated changes in mean total, HDL and non-HDL cholesterol and mean total-to-HDL cholesterol ratio by country, sex and age group. Results: Since 1980, mean TC increased in Asian countries. In Japan and South Korea, the TC rise was due to rising HDL cholesterol, which increased by up to 0.17 mmol/L per decade in Japanese women; in China, it was due to rising non-HDL cholesterol. TC declined in Western countries, except in Polish men. The decline was largest in Finland and Norway, at 0.4 mmol/L per decade. The decline in TC in most Western countries was the net effect of an increase in HDL cholesterol and a decline in non-HDL cholesterol, with the HDL cholesterol increase largest in New Zealand and Switzerland. Mean total-to-HDL cholesterol ratio declined in Japan, South Korea and most Western countries, by as much as 0.7 per decade in Swiss men (equivalent to 26% decline in coronary heart disease risk per decade). The ratio increased in China. Conclusions: HDL cholesterol has risen and the total-to-HDL cholesterol ratio has declined in many Western countries, Japan and South Korea, with only a weak correlation with changes in TC or non-HDL cholesterol.
This work was supported by the Wellcome Trust (grant numbers 101506/Z/13/Z and Research Training Fellowship 203616/Z/16/Z). R.C. acknowledges funding from the Ministry of Health of the Czech Republic (grant number 15-27109A).
Article
Versió publicada
Anglès
Lipoproteïnes de densitat alta; Lipoproteïnes de densitat baixa; Lípids de la sang; CHEMICALS AND DRUGS::Lipids::Lipoproteins::Lipoproteins, HDL::Lipids::Cholesterol, HDL; CHEMICALS AND DRUGS::Lipids::Lipoproteins::Lipoproteins, LDL::Lipids::Cholesterol, LDL; CHEMICALS AND DRUGS::Polycyclic Compounds::Fused-Ring Compounds::Steroids::Cholestanes::Polycyclic Compounds::Fused-Ring Compounds::Steroids::Cholestanes::Sterols::Cholesterol; COMPUESTOS QUÍMICOS Y DROGAS::lípidos::lipoproteínas::lipoproteínas HDL::lípidos::HDL-colesterol; COMPUESTOS QUÍMICOS Y DROGAS::lípidos::lipoproteínas::lipoproteínas LDL::lípidos::colesterol LDL; COMPUESTOS QUÍMICOS Y DROGAS::compuestos policíclicos::compuestos con anillos de fusión::esteroides::colestanos::colestenos::colesterol
Oxford University Press
https://doi.org/10.1093/ije/dyz099
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/